Leiden University | GenomeWeb

Leiden University

Through exome and targeted sequencing, researchers identified de novo mutations in at least two genes involved in a condition called Möbius syndrome.

Three individuals in a 17th century burial carried genetic signatures associated with Bantu- and non-Bantu speaking populations in parts of Cameroon, Nigeria, and Ghana.

The panel may prove useful in clinical trials of drugs interfering with mutant gene expression, the researchers said.

NEW YORK (GenomeWeb News) – Autoimmune molecular diagnostics firm Ignyta today said it is working with Leiden University Medical Center to evaluate epigenetic signatures of patients with early synovitis and rheumatoid arthritis.

FlexGen of the Netherlands said last week that China's BGI and Leiden University Medical Center will use its target enrichment technology to validate variants for the Genome of the Netherlands, or GoNL, project.

The partners plan to co-develop fluorescent in situ hybridization probes for genetic targets in bone and soft tissue tumors.

The sale follows a collaboration between Helicos and Leiden University Medical Center's forensic laboratory, which provided the company with DNA from human remains for analysis, a project the partners plan to publish.

Researchers in the Neuromuscular Disorder-Chip Consortium will use custom-designed NimbleGen Human CGH 12x135K microarrays and Human Sequence Capture 385K arrays to study the genetic underpinnings of a range of neuromuscular disorders.

The firm will use the undisclosed amount to optimize the protocols for its genomic-selection application and to start building a sales and marketing force that "will become more visible in the second half of this year," CEO Fred Dom said.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.